Since many vertebral fractures are found by chance and it is difficult to date these fractures, we do not know whether time from fracture modifies the risk conferred by the fracture. It has been suggested but not confirmed by data that the greatest risk of a second fracture exists during the time immediately following the initial fracture. 12 If true, this highlights the clinical importance of fracture identification as soon after the event as possible. To evaluate this issue, we analyzed data from women in the placebo groups of 4 large clinical trials conducted at 373 study centers in North America, Europe, Australia, and New Zealand to determine whether risk of vertebral fracture is increased in the period immediately following a vertebral fracture.
METHODS
The study population consisted of women who had been randomly assigned to a placebo group in 4 large 3-year clinical trials conducted from November 1993 to April 1998 evaluating the efficacy of risedronate, a bisphosphonate, for treatment of postmenopausal osteoporosis. [13] [14] [15] These women had either prevalent vertebral fractures (2 studies), 13, 14 low femoral neck BMD, or risk factors for hip fracture. 15 All subjects received calcium supplementation (1000 mg/d). Women with serum 25-hydroxyvitamin D levels of less than 16 ng/mL (40 nmol/L) at baseline also received vitamin D supplementation (up to 500 IU/d).
Lateral spine radiographs were obtained at baseline for evaluation of prevalent vertebral fractures and annually thereafter for incident vertebral fractures, as previously described. 13, 14 The vertebral fracture analyses included all placebo subjects who had both baseline and postbaseline evaluable radiographs. Clinical vertebral fractures were recorded as adverse events and diagnosed by a physician.
Demographic and baseline characteristics were summarized using descriptive statistics for subjects receiving placebo. The incidence of new vertebral fractures, based on time to first incident fracture, was analyzed using survival analysis methods. The cumulative incidence was calculated using Kaplan-Meier estimates. A Cox regression model was used to compare risk of incident vertebral fracture in subjects with prevalent fracture compared with those without prevalent fracture; similar methods were used to investigate risk of additional vertebral fracture within 1 year of a vertebral fracture that occurred during the study. The effect of potential baseline covariates (age, weight, lumbar spine BMD, and vitamin D status) was investigated by adjusting for these covariates as continuous variables in the Cox regression model.
RESULTS
A total of 4356 subjects were randomly assigned to placebo study arms; of these, vertebral fracture status was known for 2725 (57%). The baseline characteristics of these subjects (98% white) are shown in 
COMMENT
Vertebral fractures are a serious and irreversible outcome of osteoporosis. Previous data have demonstrated that risk of vertebral fracture is increased among women in whom a prior vertebral fracture is identified. Our data are consistent with these reports, with the RR of new vertebral fracture increasing with the number of baseline vertebral fractures. The design of our clinical trials also allowed for identification of vertebral fractures on an annual basis (incident fractures). These incident vertebral fractures also increased risk of future vertebral fractures and this increased risk appeared to be greatest in the initial year following the fracture. Twenty-three percent of incident fractures were clinical events, similar to the relationship between clinical and radiological fractures observed previously. 2 Our finding that almost 20% of women will experience another fracture within 1 year of an incident vertebral fracture has important clinical implications. The increased fracture risk in the immediate period following a fracture demonstrates the urgency of identification and intervention for this segment of the population and was observed despite that all subjects received calcium and vitamin D.
The presence of prevalent fractures significantly enhanced risk after an incident fracture (4% with 0 vs 24% with Ն2). While BMD values were available only for a subset of the population, there was a 60% increase in risk of vertebral fracture during the first year of the study for each 1-SD decrease in baseline BMD value below the mean for a young, healthy population. Thus, the combination of low lumbar spine BMD and prevalent fractures is the best predictor of increased fracture risk in the immediate period after a fracture.
There are some limitations to our findings. First, clinical trial subjects may differ from patients commonly seen in clinical practice. The similarity of our findings to those already reported with regard to the effect of prevalent fractures in predicting future fractures suggests that our results may be generalized to the postmenopausal population with osteoporosis. As in observational studies, we do not know the timing of the fractures observed at baseline. Some may have been recent, which would lead to a higher-than-expected incidence in the first year and would be expected to diminish the differences we observed. Because we do not know the timing of the fractures that existed at baseline, our data do not allow us to evaluate an important clinical question: whether an incident fracture, compared with a history of fracture, leads to greater risk for fracture. Baseline BMD values were available for approximately one third of our subjects; thus, we cannot completely correct for the effects of BMD. However, other studies have shown consistently that the effects of prevalent fractures are independent of BMD. 6, 9, 10 We have confirmed that prevalent fractures increase risk of further vertebral fractures and have shown for the first time, to our knowledge, that incident vertebral fractures exacerbate this effect. Our finding that approximately 20% of women will experience another fracture within the first year of a vertebral fracture justifies a degree of urgency for clinicians in identifying and treating all patients who present with vertebral fractures. These data indicate that osteoporosis actually may be a quickly progressing disease once a fracture occurs. Further research should be carried out to determine whether an incident fracture, compared with a history of fracture, leads to greater future risk for fracture. Seeman) . maceuticals, Aventis, and SKB. ticals. Author Contributions: Dr Lindsay participated in study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, administrative, technical, or material support, and study supervision. Dr Silverman participated in analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, and study supervision. Dr Cooper participated in study concept and design, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, statistical expertise, administrative, technical, or material support, and study supervision. Dr Hanley participated in acquisition of data, critical revision of the manuscript for important intellectual content, and study supervision. Mr Barton participated in study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, and statistical expertise. Dr Broy participated in acquisition of data and critical 
